ADC TOXICITY ATLAS
Payloads & linkers
Payload · Maytansinoid

Maytansine (maytansinoid derivative; ADCdb PAY0CHGPD)

Microtubule/tubulin polymerization inhibitor (antimitotic, M-phase arrest)

C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4(C1O4)C)OC(=O)[C@H](C)NC)C)\C)OC)(NC(=O)O2)O
Physicochemistry

Properties

MW
650.17 Da
XLogP3
3.28
logD₇.₄
-
TPSA
148.19 Ų
pKa
-
Charge pH 7.4
0
H-bond donors
3
H-bond acceptors
10
Bystander
No
PubChem CID
90167111
Bioactivity
ADCdb (DRG0JCWGF): Phase 1 objective response rate 22.70% (all). Preclinical xenograft tumor growth inhibition approximately 51% to 100% across cell lines. No payload IC50 reported on ADCdb/PubChem pages.
1 agent

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
TRPH-222CD22
31
9.1
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed